Abstract: This disclosure concerns methods of fabricating porous ceramic supports and supported ceramic membranes, comprising mixing a ceramic powder, a clay powder and a binder to form a mixture, kneading the mixture in an aqueous or non-aqueous medium and a humectant to form a ceramic paste, and aging the ceramic paste for at least 24 h. The ceramic powder is about 70 wt % to about 80 wt % in the ceramic paste. The clay powder is about 5 wt % to about 15 wt % in the ceramic paste. The ceramic powder has an average particle size of about 5 ?m to about 20 ?m. This disclosure also concerns porous ceramic supports and supported ceramic membranes thereof.

Abstract: Disclosed herein is a ceramic membrane for water and/or wastewater treatment, the membrane comprising a ceramic substrate having at least one surface and a membrane layer comprising core-shell particles on the at least one surface, where the core and shell are formed from materials described herein. The core of the core-shell particles is formed from one or more of the group selected from Al2O3 and ZrO2, and the shell of the core-shell particles is formed from one or more of the group selected from SiO2, TiO2 and WO3. In a preferred embodiment, the core is Al2O3 and the shell is SiO2.

Abstract: Embodiments of the present disclosure pertain to methods of reducing hematopoiesis in a subject by administering to the subject a therapeutically effective amount of an inhibitor of Srebp2. Additional embodiments of the present disclosure pertain to compositions for reducing hematopoiesis in a subject. In some embodiments, the compositions include a therapeutically effective amount of an inhibitor of Srebp2. Further embodiments of the present disclosure pertain to methods of enhancing hematopoiesis in a subject by administering to the subject a therapeutically effective amount of an active ingredient. Additional embodiments of the present disclosure pertain to compositions for enhancing hematopoiesis in a subject. In some embodiments, the compositions of the present disclosure include active ingredients that enhance hematopoiesis in the subject.